Smart screening

The aim of PharmaInformatic is to offer new technologies to the pharmaceutical industry, to facilitate more effective and economical drug development. One of our primary goals is to identify compounds in specific areas that are suitable for further development.

 
Why screen everything?

Save time and money by smart screening.
 

Buying external compounds?

We’ll give you advice in choosing the right compounds for your needs!

See service for further information.
 

Our computational methods to assess drug properties allow us to detect undesirable compounds in an early stage of the drug discovery process. MolScore-products help to select compounds with a high probability of success.

By implementing our smart screening approach, it is possible to secure the same number of hits while testing far fewer compounds. As a result, you can save money on compound acquisition, laboratory costs, reagents, labour and disposal.

Recent progress in High-Throughput Screening (HTS), combinatorial chemistry, molecular biology and the input from chemInformatics and bioInformatics have radically changed the approach to drug discovery in the pharmaceutical industry.

At present, about a million molecules have to be tested to find one substance, which comes up to market and generates profit.

 
By using our platform technology, we can detect relationships between complex molecular patterns and specific biological activity of molecules.